scholarly journals Acetate metabolism in lactating sheep

1982 ◽  
Vol 48 (2) ◽  
pp. 319-328 ◽  
Author(s):  
D. W. Pethick ◽  
D. B. Lindsay

1. The metabolism of acetate, glucose and D(−)-3-hydroxybutyrate was studied in lactating and non lactating sheep in vivo. Special consideration was given to the utilization by hind-limb muscle in both groups of sheep and the uptake of nutrients by the lactating mammary gland was also measured.2. The entry of acetate into the circulation (mmol/h per kg body-weight) was similar in all experimental animals at a given arterial concentration of acetate. However, normal lactation was associated with a reduced extraction of acetate by muscle and the 'spared' acetate was comparable with that removed by the udder. Feeding lactating ewes a 700 g concentrate/kg ration tended to prevent this redistribution of acetate utilization.3. The muscle of non-lactating ewes utilized sufficient glucose, when corrected for lactate release, to account for 57% of the oxygen utilization by muscle. In lactation this fell to 32%, largely because of an increased lactate production. D(−)-3-Hydroxybutyrate utilization by muscle accounted for 16–17% of the O2 consumed by the muscle in non-lactating and lactating sheep.4. Lactating mammary gland metabolism in sheep was similar to published values for dairy cows and goals. Thus the extraction (%) of glucose, O2, acetate and D(−)-3-hydroxybutyrate was 25, 28, 62 and 53 respectively. Blood flow was 529 ml/min per kg udder and the ratio blood flow: milk flow was 475. Glucose used by the udder relative to the whole animal utilization rate may be less in sheep than in cows and goats, but the comparable proportion for acetate is as large or larger than in these species.

1994 ◽  
Vol 267 (1) ◽  
pp. R1-R6 ◽  
Author(s):  
F. R. Backwell ◽  
B. J. Bequette ◽  
D. Wilson ◽  
A. G. Calder ◽  
J. A. Metcalf ◽  
...  

Specific use by the mammary gland in vivo of amino acids (AA) of peptide origin has been demonstrated in lactating dairy goats using a dual-labeled tracer technique involving close-arterial (external pudic artery, EPA) infusion of 13C-labeled dipeptides. The extent of utilization does not appear to differ for glycyl-L-[1-13C]phenylalanine and glycyl-L-[1-13C]leucine, perhaps indicative of a common mechanism by which AA are incorporated from peptide into milk protein. [1-13C]phenyl-alanine of peptide origin appears to be concentrated within the red blood cell, suggesting a role for the erythrocyte in peptide metabolism in vivo. In conclusion, it appears that the lactating mammary gland of goats has the ability to utilize AA of peptide origin for milk protein synthesis, and while the mechanism by which [1-13C]AA are incorporated into milk protein is not clear, it may involve peptide hydrolysis by either mammary cell surface or red blood cell hydrolases followed by uptake of liberated AA by the mammary gland.


2001 ◽  
Vol 359 (3) ◽  
pp. 557-565 ◽  
Author(s):  
Benjamin MILLOT ◽  
Marie-Louise FONTAINE ◽  
Dominique THEPOT ◽  
Eve DEVINOY

The aim of the present study was to identify the functional domains of the upstream region of the rabbit whey acidic protein (WAP) gene, which has been used with considerable efficacy to target the expression of several foreign genes to the mammary gland. We have shown that this region exhibits three sites hypersensitive to DNase I digestion in the lactating mammary gland, and that all three sites harbour elements which can bind to Stat5 in vitro in bandshift assays. However, not all hypersensitive regions are detected at all stages from pregnancy to weaning, and the level of activated Stat5 detected in the rabbit mammary gland is low except during lactation. We have studied the role of the distal site, which is only detected during lactation, in further detail. It is located within a 849bp region that is required to induce a strong expression of the chloramphenicol acetyltransferase reporter gene in transfected mammary cells. Taken together, these results suggest that this region, centred around a Stat5-binding site and surrounded by a variable chromatin structure during the pregnancy–lactation cycle, may play a key role in regulating the expression of this gene in vivo. Furthermore, this distal region exhibits sequence similarity with a region located around 3kb upstream of the mouse WAP gene. The existence of such a distal region in the mouse WAP gene may explain the differences in expression between 4.1 and 2.1kb mouse WAP constructs.


1985 ◽  
Vol 13 (5) ◽  
pp. 876-877 ◽  
Author(s):  
JUAN R. VIÑA ◽  
ARGIMIRO RODRIGUEZ ◽  
JUAN B. MONTORO ◽  
ANTONIO IRADI ◽  
INMACULADA R. PUERTES ◽  
...  

1995 ◽  
Vol 269 (4) ◽  
pp. R848-R855 ◽  
Author(s):  
K. Stelwagen ◽  
V. C. Farr ◽  
S. R. Davis ◽  
C. G. Prosser

The suitability of the Ca2+ chelator ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) to induce disruption of mammary tight junctions (TJ) and its effect on milk secretion were investigated in six goats. EGTA was administered via the teat of one gland as an isosmotic (300 mosmol/l) K-EGTA solution (68 mM EGTA), whereas the control gland received an isosmotic sucrose solution. Lactose, Na, K, and Cl in milk, blood lactose, and the presence of Evans blue (EB) in mammary lymph were used as indicators of TJ disruption. EGTA caused transient (approximately 60 h) changes (P < 0.05) in the concentration of lactose, K, Na, and Cl in milk, consistent with loss of TJ integrity. This was confirmed by a rapid (< 1 h) increase (P < 0.05) in blood lactose levels. Moreover, EB appeared in lymph < 1 h after EGTA+EB treatment. Milk secretion declined unilaterally by 15% (P < 0.05) after EGTA and did not return to baseline until approximately 60 h after EGTA. EGTA caused a unilateral, temporary (first 7 h) increase in mammary blood flow. This study shows that a rapid temporary disruption of mammary TJ can be successfully induced in vivo and that such disruption compromises milk secretion.


1989 ◽  
Vol 40 (4) ◽  
pp. 879 ◽  
Author(s):  
PM Harris ◽  
DW Dellow ◽  
BR Sinclair

An arterio-venous preparation was developed which allowed infusion into, and/or sampling from, branches of the deep circumflex iliac artery and vein supplying and draining a discrete area of skin on the abdominal flank of Romney sheep.Measurements of blood flow (using dye dilution techniques), utilization or output of energy metabolites (oxygen, glucose, lactate and acetate) and amino acid metabolism were made in relation to whole body protein and energy metabolism.Measurements on the patch suggested that blood flow to the total skin was about 6% of cardiac output but that only 1-2% of whole body oxygen utilization occurred in the skin. This was partly accounted for by a significant proportion of glucose uptake (1.15 g day-1) being anaerobically oxidized to lactate (0.41 g day-1). Measurements of protein synthesis in the patch showed that between 10 and 16% of whole body protein synthesis occurs in the skin.Results from the preparation demonstrate that it is a useful procedure to study metabolism in a defined patch of skin in the intact animal.


1983 ◽  
Vol 212 (3) ◽  
pp. 843-848 ◽  
Author(s):  
G F Gibbons ◽  
C R Pullinger ◽  
M R Munday ◽  
D H Williamson

The activity of 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA reductase; EC 1.1.1.34) in the lactating mammary gland of rats killed between 10:00 and 14:30 h was 2-3 times that in the livers of the same animals. In contrast, after injection of 3H2O in vivo, the rate of appearance of 3H in the cholesterol of the gland was much lower than that in the liver. In the mammary gland of virgin and non-lactating animals, the activity of HMG-CoA reductase was less than 10% of that of the lactating gland. The activity of HMG-CoA reductase in the lactating mammary gland was significantly (P less than 0.005) lower at midnight than at mid-day, and appeared to show an inverse relationship to the activity of the liver enzyme. However, there was no corresponding change in the incorporation of 3H into the gland cholesterol. Withdrawal of food for 6h had no effect on the activity of HMG-CoA reductase in the lactating mammary gland, but resulted in a significant decrease (P less than 0.005) in that of the liver. Starvation of lactating rats for 24h produced a significant decrease (P less than 0.005) in the activity of the enzyme in both organs. There was also a significant decline in the rate at which 3H2O was incorporated in vivo into the cholesterol of both organs (liver, P less than 0.05; gland, P less than 0.005). Giving a high-fat palatable diet together with chow to lactating animals led to a decline in HMG-CoA reductase activity in the mammary gland, but not in liver. This decrease in the gland was not accompanied by a corresponding decline in the apparent rate of cholesterol synthesis.


1957 ◽  
Vol 146 (924) ◽  
pp. 400-415 ◽  

This work was undertaken to find if a study of oxidation-reduction potentials, pH and oxygen tension would yield information concerning physiological changes induced in lactating mammary glands of rats and rabbits by hormones and other substances. Breathing oxygen at atmospheric pressure caused a rapid rise in oxygen tension in lactating mammary gland, and a small, slower rise of oxidation-reduction potential. Breathing nitrogen had the opposite effect. Oxytocin caused a rapid temporary fall of oxidation-reduction potential, synchronous with milk ejection. With adrenaline the response was more rapid and the oxygen tension fell to zero, to recover within 2 min. Vasopressin produced a slower fall and recovery. Insulin (35 μ g/kg) caused a preliminary rise of oxidation-reduction potential, followed by a fall lasting 1 h. The fall could be largely abolished by glucose. The synthetic oestrogen doisynolic acid caused a triphasic response in the oxidation-reduction potentials and increased oxygen tension in the gland. It reduced, but did not abolish, the changes due to insulin. Desoxycorticosterone glucoside caused a slow rise of oxidation-reduction potential, but did not alter the response to insulin. Intermedin caused a small rise of oxidation-reduction potential. The effects produced by commercial ACTH may have been due to the oxytocin and intermedin present. Growth hormone induced a small diphasic change in the oxidation-reduction potentials. The radiosensitizers tetrasodium 2-methyl-1:4-naphthohydroquinone diphosphate and tetrasodium trimethyl-hydroquinone diphosphate produced marked falls of oxidation-reduction potential even with small doses, without change of oxygen tension. Intravenous potassium ferricyanide appeared to liberate oxygen from haemoglobin in vivo . The pH of mammary gland became slightly more acid after breathing oxygen, and also in the preliminary response to insulin, glucose, doisynolic acid and desoxycorticosterone glucoside; and after oxytocin, vasopressin and growth hormone.


1984 ◽  
Vol 223 (2) ◽  
pp. 345-351 ◽  
Author(s):  
R G Jones ◽  
V Ilic ◽  
D H Williamson

Starvation for 6h and 24h caused an 80% and 95% decrease in the rate of mammary-gland lipogenesis respectively in conscious lactating rats. 2. Plasma insulin concentrations decreased and circulating ketone-body concentrations increased with the length of starvation. 3. The inhibition of lipogenesis after 24h starvation was accompanied by increased concentrations of glucose, glucose 6-phosphate and citrate in the mammary gland. Qualitatively similar changes were observed after 6h starvation. 4. Infusion of insulin at physiological concentrations caused a 100% increase in the rate of lipogenesis in fed animals and partially reversed the inhibition of lipogenesis caused by starvation. 5. Infusion of insulin tended to reverse the changes seen in intracellular metabolite concentrations. 4. Infusion of glucagon into fed rats caused no change in the rates of lipogenesis in mammary gland, liver or white adipose tissue. 7. It is concluded that (a) insulin acts physiologically to regulate lipogenesis in the mammary gland, (b) hexokinase and phosphofructokinase are important regulatory enzymes in the short-term control of lipogenesis in the mammary gland, which are under the influence of insulin, and (c) the unresponsiveness of mammary-gland lipogenesis in vivo to infusions of glucagon is consistent with an adaptive mechanism which diverts substrate towards the lactating mammary gland and away from other tissues.


1988 ◽  
Vol 250 (1) ◽  
pp. 269-276 ◽  
Author(s):  
S W Mercer ◽  
D H Williamson

1. Oral administration of triacylglycerol (triolein) to starved/chow-refed lactating rats suppressed the lipogenic switch-on in the mammary gland in vivo. 2. A time-course study revealed that triolein, administered at 30 min after the onset of refeeding, had no influence on lipogenic rate in the mammary gland between 30 and 60 min, but markedly decreased it between 60 and 90 min. Glucose uptake by the mammary gland (arteriovenous difference) increased by 30 min of refeeding, as did lactate production. Between 30 and 90 min glucose uptake remained high in the control animals, but glucose uptake and net C3-unit uptake were decreased in the triolein-loaded animals by 90 min. 3. Triolein increased [glucose 6-phosphate] in the gland and simultaneously decreased [fructose 1,6-bisphosphate], indicative of a decrease in phosphofructokinase activity. This cross-over occurred at 60 min, i.e. immediately before the inhibition of lipogenesis, and by 90 min had reached ‘starved’ values. 4. Triolein had no effect on plasma [insulin] nor on whole-blood [glucose], [lactate] or [3−hydroxybutyrate]; a small increase in [acetoacetate] was observed. 5. Infusion of the lipoprotein lipase inhibitor, Triton WR1339, abolished the suppression of mammary-gland lipogenesis by triolein and the increase in the [glucose 6-phosphate]/[fructose 1,6-bisphosphate] ratio, suggesting a direct influence of dietary lipid on mammary-gland glucose utilization and phosphofructokinase activity.


1985 ◽  
Vol 232 (3) ◽  
pp. 931-934 ◽  
Author(s):  
S Ward ◽  
N J Kuhn

The fructose 2,6-bisphosphate (Fru-2,6-P2) content and intracellular concentration of lactating mammary gland was measured in fed, starved and re-fed rats. There was little or no change on starvation, and about 1.5-fold rise on re-feeding, contrasting with estimated glycolytic changes of about 10-fold. The 6-phosphofructokinase (PFK-1) activity of mammary extracts was highly sensitive to added Fru-2,6-P2 under all conditions examined, and appeared to approach saturation at physiological concentrations of this effector. The activity of mammary PFK-1 measured under optimal and ‘physiological’ conditions suggested that this enzyme operates in vivo at about 24% of maximal rate, and is likely to be an important rate-limiting factor in mammary glycolysis.


Sign in / Sign up

Export Citation Format

Share Document